KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Capital Expenditures: 2009-2025

Historic Capital Expenditures for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $35.6 million.

  • Charles River Laboratories International's Capital Expenditures fell 8.11% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.8 million, marking a year-over-year decrease of 12.67%. This contributed to the annual value of $233.0 million for FY2024, which is 26.86% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Capital Expenditures is $35.6 million, which was up 0.80% from $35.3 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Capital Expenditures ranged from a high of $106.9 million in Q2 2023 and a low of $28.0 million during Q1 2021.
  • Moreover, its 3-year median value for Capital Expenditures was $65.9 million (2023), whereas its average is $62.0 million.
  • Per our database at Business Quant, Charles River Laboratories International's Capital Expenditures soared by 187.06% in 2022 and then crashed by 41.40% in 2024.
  • Charles River Laboratories International's Capital Expenditures (Quarterly) stood at $98.8 million in 2021, then dropped by 9.87% to $89.0 million in 2022, then fell by 12.02% to $78.3 million in 2023, then dropped by 3.46% to $75.6 million in 2024, then declined by 8.11% to $35.6 million in 2025.
  • Its Capital Expenditures stands at $35.6 million for Q3 2025, versus $35.3 million for Q2 2025 and $59.3 million for Q1 2025.